July 8, 2010 – Boston Scientific Corp. today announced enrollment of the first patient in its MultiSENSE clinical trial, which the company plans to use to develop a clinical alert identifying the early onset of worsening heart failure. The trial is designed to evaluate multiple physiologic sensors in the company’s Cognis cardiac resynchronization therapy defibrillators (CRT-Ds).

July 7, 2010 – Medical imaging company NovaRad recently expanded its distributor network by adding NXC Imaging to serve facilities in Wisconsin, South Dakota, North Dakota and parts of Illinois, Montana and Michigan. NXC Imaging will represent NovaRad’s products including:

July 6, 2010 – Maquet Cardiovascular LLC recently announced it will become the exclusive U.S. distributor of the InterGard family of vascular grafts. This will go into effect on Oct. 1, 2010, when its current distribution agreement with W.L. Gore & Associates expires.

July 6, 2010 – The development of a new magnetic resonance imaging (MRI) technology, which may revolutionize the way medical conditions are diagnosed and treated, is to take a major step forward as a $10.6 million research center is established at the University of York.

July 6, 2010 – Ultrasound company SonoSite Inc. announced last week that it has completed its acquisition of privately held VisualSonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology, for $67.9 million net of cash and debt.

July 1, 2010 – The U.S. Food and Drug Administration (FDA) recently added a warning to the information on clopidogrel (Plavix), as a result of new information indicating that variations in genetic makeup can prevent the medication from reducing patients’ risk for heart attack and stroke.